| Schedule of calculation of earnings (loss) per share |
| | | | | | | | | | | | | | | Unaudited | | Unaudited | | | For the Three Months | | For the Six Months | | | Ended December 31, | | Ended December 31, | | | 2025 | | 2024 (1) | | 2025 | | 2024 | | | | | | | Net income applicable to common stock | | $ | 501,396 | | $ | 51,127 | | $ | 945,689 | | $ | 226,034 | | | | | | | | | | | | | | Average number of shares outstanding | | | 2,914,021 | | | 2,894,022 | | | 2,914,021 | | | 2,895,216 | Less: Average unallocated ESOP shares | | | 227,984 | | | 101,381 | | | 229,165 | | | 101,981 | | | | | | | | | | | | | | Average number of common shares outstanding used to calculate basic earnings per share | | | 2,686,037 | | | 2,792,641 | | | 2,684,856 | | | 2,793,235 | Effect of dilutive restricted stock awards and stock options | | | 12,826 | | | 1,297 | | | 9,165 | | | — | Average number of common shares outstanding used to calculate diluted earnings per share | | | 2,698,863 | | | 2,793,938 | | | 2,694,021 | | | 2,793,235 | | | | | | | | | | | | | | Earnings per common share: | | | | | | | | | | | | | Basic | | $ | 0.19 | | $ | 0.02 | | $ | 0.35 | | $ | 0.08 | Diluted | | | 0.19 | | | 0.02 | | | 0.35 | | | 0.08 | | | | | | | | | | | | | |
(1) | Share amounts related to periods prior to the April 21, 2025 closing of the conversion offering have been restated to give retroactive recognition to the 1.3728 exchange ratio applied in the conversion offering (see Note 1). |
|